At 4YFN, a space dedicated to startups at the Mobile World Congress in Barcelona, not only has there been talk of telecommunications and devices, but also of the latest advances in the field of digital health. Thus, at this world-renowned event on technical and scientific progress, Boehringer Ingelheim organized a meeting with top experts to analyze the possibilities of artificial intelligence in healthcare systems.
Artificial Intelligence (AI) is increasingly becoming a hot topic and focus of expert predictions across all fields, no longer confined to the realm of science fiction. According to a 2023 study by the University of Salamanca, 44.81% of the 684 Spanish respondents showed interest in Al, with 85.6% asserting its potential positive impact on society. One of the most socially impactful applications of Al could be in clinical practice. This was a focus at the Mobile World Congress (MWC), where Boehringer Ingelheim hosted a session discussing Al’s potential in healthcare, particularly in health systems. The event gathered over 200 specialists, including innovation and digital health leaders, hospital managers, academics, and startups, as well as various national and international political and management speakers. The company’s commitment to digital health and innovation was evident in its opening of a pavilion dedicated solely to digital health and sustainability. Al is revolutionizing healthcare through more accurate diagnoses, personalized treatments, and increased process efficiency. The meeting in Barcelona included two roundtables focused on preparing health systems to integrate Al and the current impact of Al on healthcare. The discussions highlighted the need for regulatory frameworks to facilitate the evaluation and funding of digital solutions incorporating Al, always considering the patient’s perspective. The experts agreed that Al offers an opportunity to ensure equitable healthcare for all citizens. The real-world cases presented demonstrated how Al can streamline data analysis, create new patient experiences, improve diagnosis and treatment, and optimize processes. In conclusion, in a world of increasing geopolitical and social uncertainties, the potential of innovation and digital health offers an opportunity for an effective transformation of the health system, guaranteeing better care and experience for patients. Al plays an increasingly significant role in this, allowing health managers and professionals to make more informed and precise decisions. Embracing disruptive technological innovations, changing mindsets, and adopting new business models are key, always with a strong commitment to quality, impact, and scientific and social progress. Boehringer Ingelheim, a leading biopharmaceutical research company, stood out at the MWC with its strong positioning in digital health and innovation.
